Momelotinib a JAK inhibitor vs Danazol in Myelofibrosis Myeloproliferative Disease 14 Mins Read3 Momelotinib Shows Promising JAK and ALK2 Inhabitation in Patients With Anemic Myelofibrosis: MOMENTUM Study It’s my pleasure today to discuss…
